Health Care’s New Frontier
Because access to medicine in poor countries is a multifaceted challenge, it is best tackled by several parties. Lasting, collaborative relationships among pharmaceutical companies, governments, nonprofit organizations, and community leaders are needed to help disadvantaged populations overcome their health-care constraints.
https://prosyn.org/hAxMkOQ
BEIJING – Developing countries face a seemingly insurmountable hurdle in providing health care to their rapidly growing – or, in some cases, rapidly aging – populations, especially as health systems become increasingly over-burdened and infections and other diseases spread. Because access to medicine in these regions is a multifaceted challenge, it is best tackled by several parties.